LCN2 and familial pancreatic carcinoma: For instance, Liu et al. identified NUPR1 as a key inhibitor of ferroptosis, demonstrating that it transcriptionally activates lipocalin-2 (LCN2), which significantly mitigates oxidative damage and suppresses ferroptosis in pancreatic cancer cells [67, 68].